Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients
Clinical trial NCT01402401 · TERMINATED
Trial details
- NCT number
- NCT01402401
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-06-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.